Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MRI phenotypes in MS
Christopher C. Hemond, Brian C. Healy, Shahamat Tauhid, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 2
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Emerging imaging and liquid biomarkers in multiple sclerosis
Alexander J. Gill, Emily Schorr, Sachin P. Gadani, et al.
European Journal of Immunology (2023) Vol. 53, Iss. 8
Open Access | Times Cited: 24
7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions
Jonathan Zurawski, Shahamat Tauhid, Renxin Chu, et al.
Multiple Sclerosis Journal (2019) Vol. 26, Iss. 2, pp. 177-187
Open Access | Times Cited: 63
microRNA and exosome profiling in multiple sclerosis
Marcin P. Mycko, Sergio E. Baranzini
Multiple Sclerosis Journal (2020) Vol. 26, Iss. 5, pp. 599-604
Open Access | Times Cited: 63
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review
Hafiz Muhammad Husnain Azam, Rosa Rößling, Christiane Geithe, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 7
Emerging Biomarkers of Multiple Sclerosis in the Blood and the CSF: A Focus on Neurofilaments and Therapeutic Considerations
Tamás Biernacki, Zsófia Kokas, Dániel Sandi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3383-3383
Open Access | Times Cited: 25
Diagnosis and treatment of progressive multiple sclerosis: A position paper
Carlo Pozzilli, Maura Pugliatti, Patrick Vermersch, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 1, pp. 9-21
Open Access | Times Cited: 24
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
Sinje Gehr, Thomas Kaiser, Reinhold Kreutz, et al.
The EPMA Journal (2019) Vol. 10, Iss. 4, pp. 425-436
Open Access | Times Cited: 40
Remyelination in multiple sclerosis from the miRNA perspective
Karina Maciak, Angela Dziedzic, Joanna Saluk
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Principal component analysis of blood microRNA datasets facilitates diagnosis of diverse diseases
Stacy L. Sell, Steven G. Widen, Donald S. Prough, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234185-e0234185
Open Access | Times Cited: 28
Fluid phase biomarkers in multiple sclerosis
Krzysztof Selmaj, Marcin P. Mycko, Roberto Furlan, et al.
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 286-292
Closed Access | Times Cited: 14
An Insight into the microRNAs Associated with Arteriovenous and Cavernous Malformations of the Brain
Ioan Alexandru Florian, Andrei Buruiană, Teodora Larisa Timiș, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1373-1373
Open Access | Times Cited: 15
miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis
María Muñoz‐San Martín, Imma Gómez, Ana Quiroga‐Varela, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome
Raphaël Schneider, Koroboshka Brand‐Arzamendi, Timothy Lim, et al.
Multiple Sclerosis Journal (2023) Vol. 30, Iss. 2, pp. 156-165
Closed Access | Times Cited: 6
miRNA 548a-3p as biomarker of NEDA-3 at 2 years in multiple sclerosis patients treated with fingolimod
Alicia González‐Martínez, Rohit Patel, Brian C. Healy, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study
Omar Deeb, Maisa Nabulsi
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 26, pp. 2391-2403
Closed Access | Times Cited: 14
Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study
Rohit Bakshi, Brian C. Healy, Sheena L. Dupuy, et al.
Journal of Neuroimaging (2020) Vol. 30, Iss. 2, pp. 212-218
Open Access | Times Cited: 13
Early life stress enhances the susceptibility to depression and interferes with neuroplasticity in the hippocampus of adolescent mice via regulating miR-34c-5p/SYT1 axis
Shuwen Yu, Yijing Zhao, Qian Luo, et al.
Journal of Psychiatric Research (2023) Vol. 170, pp. 262-276
Closed Access | Times Cited: 4
Molekulare Biomarker bei neuroinflammatorischen Erkrankungen
Louisa Müller‐Miny, Jan D. Lünemann
Neurologie up2date (2024) Vol. 07, Iss. 01, pp. 29-44
Closed Access | Times Cited: 1
Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function
Daniela Pinter, Christian F. Beckmann, Franz Fazekas, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 10
MiR-361-5p promotes oxygen–glucose deprivation/re-oxygenation induced neuronal injury by negatively regulating SQSTM1 in vitro
Tao Zeng, Sai Zhang, Yan He, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 8, pp. 2359-2368
Closed Access | Times Cited: 9
The role of non-coding RNAs in neuroinflammatory process in multiple sclerosis
A Nowak, Zofia Wicik, M Wolska, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 8, pp. 4651-4668
Closed Access | Times Cited: 6
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate
María Inmaculada Domínguez‐Mozo, Ignacio Casanova, Laura De Torres, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Angiogenesis and Multiple Sclerosis Pathogenesis: A Glance at New Pharmaceutical Approaches
Maria Teresa Gentile, Gianluca Muto, Giacomo Lus, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4643-4643
Open Access | Times Cited: 6
MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate
Ignacio Casanova, María Inmaculada Domínguez‐Mozo, Laura De Torres, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2760-2760
Open Access | Times Cited: 3
Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients
Sandra M. Hurtado Rúa, Ulrike W. Kaunzner, Sneha Pandya, et al.
European Journal of Neurology (2021) Vol. 29, Iss. 1, pp. 237-246
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top